RACHEL HANSEN: Open Payments
NPI 1932728813 · LEHI, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,063 in 70 payments from 14 companies in 2025. Trend: 2023 $1,107 · 2024 $1,790 · 2025 $1,063
Food & beverage: $1,045Education: $18
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $323 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $207 |
| Janssen Biotech, Inc. | 12 | $154 |
| Madrigal Pharmaceuticals | 3 | $57 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| Phathom Pharmaceuticals, Inc. | 4 | $53 |
| Celltrion USA Inc. | 2 | $45 |
| GENZYME CORPORATION | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| ORPHALAN INC | 1 | $33 |
Products named: RINVOQ, ENTYVIO, TREMFYA, DUPIXENT, REZDIFFRA, VOQUEZNA, VEGZELMA, SKYRIZI.
Industry payments across UT — which companies pay providers there.
